Duchêne B - Search Results

1

A novel anti-galectin-9 immunotherapy limits the early progression of pancreatic neoplastic lesions in transgenic mice.

Quilbe A, Mustapha R, Duchêne B, Kumar A, Werkmeister E, Leteurtre E, Moralès O, Jonckheere N, Van Seuningen I, Delhem N. Quilbe A, et al. Among authors: duchene b. Front Immunol. 2023 Nov 30;14:1267279. doi: 10.3389/fimmu.2023.1267279. eCollection 2023. Front Immunol. 2023. PMID: 38098486 Free PMC article.

2

Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma.

Boukrout N, Souidi M, Lahdaoui F, Duchêne B, Neve B, Coppin L, Leteurtre E, Torrisani J, Van Seuningen I, Jonckheere N. Boukrout N, et al. Among authors: duchene b. Cancers (Basel). 2021 Dec 9;13(24):6197. doi: 10.3390/cancers13246197. Cancers (Basel). 2021. PMID: 34944818 Free PMC article.

3

A new pancreatic adenocarcinoma-derived organoid model of acquired chemoresistance to FOLFIRINOX: First insight of the underlying mechanisms.

Hadj Bachir E, Poiraud C, Paget S, Stoup N, El Moghrabi S, Duchêne B, Jouy N, Bongiovanni A, Tardivel M, Weiswald LB, Vandepeutte M, Beugniez C, Escande F, Leteurtre E; OrgaRES consortium; Poulain L, Lagadec C, Pigny P, Jonckheere N, Renaud F, Truant S, Van Seuningen I, Vincent A. Hadj Bachir E, et al. Among authors: duchene b. Biol Cell. 2022 Jan;114(1):32-55. doi: 10.1111/boc.202100003. Epub 2021 Oct 16. Biol Cell. 2022. PMID: 34561874

4

The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family.

Skrypek N, Duchêne B, Hebbar M, Leteurtre E, van Seuningen I, Jonckheere N. Skrypek N, et al. Among authors: duchene b. Oncogene. 2013 Mar 28;32(13):1714-23. doi: 10.1038/onc.2012.179. Epub 2012 May 14. Oncogene. 2013. PMID: 22580602 Free PMC article.

5

The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42-44 MAPK, Akt, Bcl-2 and MMP13 pathways.

Tréhoux S, Duchêne B, Jonckheere N, Van Seuningen I. Tréhoux S, et al. Among authors: duchene b. Biochem Biophys Res Commun. 2015 Jan 16;456(3):757-62. doi: 10.1016/j.bbrc.2014.12.025. Epub 2014 Dec 13. Biochem Biophys Res Commun. 2015. PMID: 25511698

6

miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer.

Lahdaoui F, Delpu Y, Vincent A, Renaud F, Messager M, Duchêne B, Leteurtre E, Mariette C, Torrisani J, Jonckheere N, Van Seuningen I. Lahdaoui F, et al. Among authors: duchene b. Oncogene. 2015 Feb 5;34(6):780-8. doi: 10.1038/onc.2014.11. Epub 2014 Mar 10. Oncogene. 2015. PMID: 24608432

7

Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival.

Desurmont T, Skrypek N, Duhamel A, Jonckheere N, Millet G, Leteurtre E, Gosset P, Duchene B, Ramdane N, Hebbar M, Van Seuningen I, Pruvot FR, Huet G, Truant S. Desurmont T, et al. Among authors: duchene b. Cancer Sci. 2015 Mar;106(3):262-9. doi: 10.1111/cas.12603. Epub 2015 Mar 5. Cancer Sci. 2015. PMID: 25580640 Free PMC article.

8

The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2.

Skrypek N, Vasseur R, Vincent A, Duchêne B, Van Seuningen I, Jonckheere N. Skrypek N, et al. Among authors: duchene b. Oncotarget. 2015 May 10;6(13):10853-67. doi: 10.18632/oncotarget.3414. Oncotarget. 2015. PMID: 25890497 Free PMC article.

9

The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.

Vasseur R, Skrypek N, Duchêne B, Renaud F, Martínez-Maqueda D, Vincent A, Porchet N, Van Seuningen I, Jonckheere N. Vasseur R, et al. Among authors: duchene b. Biochim Biophys Acta. 2015 Dec;1849(12):1375-84. doi: 10.1016/j.bbagrm.2015.10.014. Epub 2015 Oct 22. Biochim Biophys Acta. 2015. PMID: 26477488

10

Evaluation of the expression of fatty acid synthase and O-GlcNAc transferase in patients with liver cancer by exploration of transcriptome databases and experimental approaches.

Raab S, Very N, Duchêne B, Rybarczyk P, Jonckheere N, El Yazidi-Belkoura I, Lefebvre T. Raab S, et al. Among authors: duchene b. Oncol Lett. 2022 Apr;23(4):105. doi: 10.3892/ol.2022.13225. Epub 2022 Feb 3. Oncol Lett. 2022. PMID: 35242233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page